A distinct metabolic signature of human colorectal cancer with prognostic potential

Yunping Qiu, Guoxiang Cai, Bingsen Zhou, Dan Li, Aihua Zhao, Guoxiang Xie, Houkai Li, Sanjun Cai, Dong Xie, Changzhi Huang, Weiting Ge, Zhanxiang Zhou, Lisa X. Xu, Weiping Jia, Shu Zheng, Yun Yen, Wei Jia

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Purpose: Metabolic phenotyping has provided important biomarker findings, which, unfortunately, are rarely replicated across different sample sets due to the variations from different analytical and clinical protocols used in the studies. To date, very few metabolic hallmarks in a given cancer type have been confirmed and validated by use of a metabolomic approach and other clinical modalities. Here, we report a metabolomics study to identify potential metabolite biomarkers of colorectal cancer with potential theranostic value. Experimental Design: Gas chromatography-time-of-flight mass spectrometry (GC-TOFMS)-based metabolomics was used to analyze 376 surgical specimens, which were collected from four independent cohorts of patients with colorectal cancer at three hospitals located in China and City of Hope Comprehensive Cancer Center in the United States. Differential metabolites were identified and evaluated as potential prognostic markers. A targeted transcriptomic analysis of 29 colorectal cancer and 27 adjacent nontumor tissues was applied to analyze the gene expression levels for key enzymes associated with these shared metabolites. Results: A panel of 15 significantly altered metabolites was identified, which demonstrates the ability to predict the rate of recurrence and survival for patients after surgery and chemotherapy. The targeted transcriptomic analysis suggests that the differential expression of these metabolites is due to robust metabolic adaptations in cancer cells to increased oxidative stress as well as demand for energy, and macromolecular substrates for cell growth and proliferation. Conclusions: These patients with colorectal cancer, despite their varied genetic background, mutations, pathologic stages, and geographic locations, shared a metabolic signature that is of great prognostic and therapeutic potential.

Original languageEnglish
Pages (from-to)2136-2146
Number of pages11
JournalClinical Cancer Research
Volume20
Issue number8
DOIs
Publication statusPublished - Apr 15 2014
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Fingerprint Dive into the research topics of 'A distinct metabolic signature of human colorectal cancer with prognostic potential'. Together they form a unique fingerprint.

  • Cite this

    Qiu, Y., Cai, G., Zhou, B., Li, D., Zhao, A., Xie, G., Li, H., Cai, S., Xie, D., Huang, C., Ge, W., Zhou, Z., Xu, L. X., Jia, W., Zheng, S., Yen, Y., & Jia, W. (2014). A distinct metabolic signature of human colorectal cancer with prognostic potential. Clinical Cancer Research, 20(8), 2136-2146. https://doi.org/10.1158/1078-0432.CCR-13-1939